?> Contact us Follow Us
Biosimilars Forum
  • About Us
    • Members
    • Executive Director
  • Why Biosimilars
    • The Issue
    • Our Solutions
  • Biosimilars 101
    • Foundations
    • Core Principles
    • FDA Regulatory Tenets
    • Biosimilars FAQs
    • Future Evolution of Biosimilar Development
    • Approved Biosimilars
  • Advocacy
    • Our Action
    • Tools
  • News
  • Resources
  • Get Involved
    • Partners

Archives: Resources

Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
June 6, 2022 signalgroup
Biosimilars 101 Webinar Case Study
June 1, 2022 signalgroup
Biosimilars Forum Comments on PBM Business Practices
April 25, 2022 signalgroup
Saving Billions on Healthcare Costs with Biosimilars
April 13, 2022 signalgroup
Biosimilars Basics
September 15, 2021 signalgroup
Separate Codes and Payment for Biosimilars
June 14, 2021 signalgroup
Biosimilars Have Significantly Lowered Prices of All Biologics
August 18, 2020 signalgroup
Biosimilars Forum Economic Footprint
November 11, 2019 signalgroup
Polling Shows Strong Bipartisan Support for Immediate Action on Biosimilars to Reduce Health Care Costs
October 3, 2019 signalgroup
FDA Patient Materials
July 3, 2019 Katie Quinn
State Laws and Biosimilars
  • 01
  • 02
  • 03
  • 04

  • Biosimilars 101
  • Biosimilars FAQs
  • Advocacy
  • Stay Connected
Biosimilars Forum
© 2025 Biosimilars Forum. All rights reserved.
  • Terms of Use
  • |
  • Privacy Policy
  • |
  • Contact Us